Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.17M Buy
13,488
+1,175
+10% +$100K ﹤0.01% 1558
2026
Q1
$1.1M Buy
12,313
+319
+3% +$30.6K ﹤0.01% 1441
2025
Q4
$1.11M Sell
11,994
-132
-1% -$14.4K ﹤0.01% 1422
2025
Q3
$1.51M Buy
12,126
+389
+3% +$49.5K 0.01% 1159
2025
Q2
$1.54M Buy
11,737
+11,712
+46,848% +$1.32M 0.01% 1056
2025
Q1
$2.62K Sell
25
-2,082
-99% -$218K ﹤0.01% 3455
2024
Q4
$229K Buy
+2,107
New +$235K ﹤0.01% 2023
2023
Q2
Sell
-6
Closed -$333 3562
2023
Q1
$333 Sell
6
-17
-74% -$938 ﹤0.01% 3278
2022
Q4
$861 Buy
+23
New +$1.14K ﹤0.01% 3074

Other funds holding ITRI

NewEdge Advisors's ITRI Position: Q2 2026 in Review

NewEdge Advisors increased its Itron (ITRI) stake by 9.5% in Q2 2026, buying an estimated $100K and bringing the position to 13,488 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1558.

NewEdge Advisors first reported a position in ITRI in Q4 2022 and has held it in 9 quarters since. The position peaked at $1.54M in Q2 2025. 413 funds tracked by Wall St. Rank hold ITRI as of Q2 2026.

  • NewEdge Advisors held 13,488 shares of Itron worth $1.17M as of Q2 2026.
  • NewEdge Advisors bought 1,175 Itron shares in Q2 2026, an estimated $100K.
  • Itron made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #1558 holding.
  • NewEdge Advisors first reported a position in Itron in Q4 2022 and has held it in 9 quarters since.
  • NewEdge Advisors's Itron position peaked at $1.54M in Q2 2025.
  • 413 funds tracked by Wall St. Rank held Itron as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.